ArticleScientific reports2026
Association of revised morphological uterus sonographic assessment (MUSA) features of adenomyosis and IVF outcomes.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This study aimed to investigate the association between sonographic features of adenomyosis defined by the revised MUSA criteria and pregnancy outcomes in women undergoing in vitro fertilization (IVF) and embryo transfer (ET). All autologous ET cycles at a university-affiliated infertility center in Seoul, South Korea, between May 2022 and January 2024 were included in this study. All patients undergoing IVF were examined by the ultrasound strictly adhering to the revised MUSA definition at the time of examination. Patients with sonographic features of adenomyosis were assigned to the adenomyosis group (n = 300). During the same period, an age-matched 1:1 control group (n = 300) was selected from women who underwent embryo transfer and had no sonographic features of adenomyosis. Logistic regression analysis and generalized estimating equations were used to evaluate which specific sonographic features of adenomyosis are associated with pregnancy outcomes. Among the MUSA features, the interrupted junctional zone was the only independent factor significantly associated with a lower chance of clinical pregnancy (aRR = 0.75, 95% CI 0.58-0.95, p = 0.020), ongoing pregnancy (aRR = 0.72, 95% CI 0.52-0.99, p = 0.049), and an increased risk of biochemical pregnancy loss (aRR = 1.98, 95% CI 1.02-3.84, p = 0.044). This finding suggests that sonographic evaluation of the junctional zone should be considered in women with adenomyosis who desire pregnancy.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.